Astrana Health (ASTH) late Thursday reported a Q4 net loss of $0.15 per diluted share, compared with earnings of $0.26 a year earlier.
Analysts polled by FactSet expected earnings of $0.10.
Revenue for the quarter ended Dec. 31 was $665.2 million up from $353 million a year earlier.
Analysts surveyed by FactSet expected $617.2 million.
The company expects 2025 revenue in the range of $2.5 billion to $2.7 billion. Analysts expected $2.58 billion.